Colorectal Cancer Survival Gap Between Whites and African Americans

Although colorectal cancer death rates are falling for both whites and blacks in the United States, the decline is steeper for whites and the gap between races is growing.

A new  report from the American Cancer Society, Colorectal Cancer: Facts and Figures 2008-2010, finds that African American men and women are more likely than the rest of the U.S. population to get colon or rectal cancer and much more likely to die of it.  In 2005, the death rate for African Americans was 48 percent higher than that for whites.

Officials at the ACS attribute the difference to lower colorectal cancer screening rates, poorer insurance coverage, and fewer African Americans receiving recommended surgical and chemotherapy treatments.

Incidence and death rates for Asian Americans, Hispanics, and Native Americans are lower than for white and the overall populations.

In a time of increased screening and improved treatment for colorectal cancer, the difference in survival is widening between blacks and whites.  Before 1980, African American men actually had lower death rates from colorectal cancer, and rates for black women were similar to white women.  Today 71 in every 100,000 black men and 55 in 100,000 black women will get colorectal cancer compared to 58 white men and 43 white women.

Nearly 32 per 100,000 black men will die, compared to 22 white men.  For women, the gap is 22 per 100,000 blacks versus 15 white women.

Overall, survival from colorectal cancer is improving substantially.  In the 1970′s half of people who got colorectal cancer died.  Today 65 percent or 2 out of 3 patients will survive.

Bookmark and Share

This news article was originally posted on January 5th, 2009 and was accurate at the time of publication. Since then, information may have changed or links may now be outdated. Please call our Answer Line 1-877-427-2111 for the latest information, or talk to your doctor before making any medical decisions.

Posted by Kate Murphy on January 5th, 2009
Tags: disparities

Leave a Comment Comments RSS

Your comments are welcome. However, specific medical advice will not be provided, and we urge you to consult with a qualified physician for diagnosis and for answers to your personal questions. C3 is not responsible for the medical accuracy of any comments left by persons other than C3 staff members. C3 staff members monitor comments and may respond publicly where appropriate.

Please note that we automatically publish the name that you enter next to your post. Also note that our pages are automatically indexed by Google and other search engines, and your name may therefore appear in search results on those sites. So if you wish to remain anonymous please use a different name or enter 'Anon' as the name.

We regret that we are unable to privately answer questions left as comments. So please do not include your phone number, email or mailing address in the body of your comment. For the best personal and direct response to your colorectal cancer treatment questions, please call our Answer Line at 1-877-4CRC-111 (1-877-427-2111).

Search C3

Register to receive our free e-newsletter

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe